Results of a prospective, randomized, placebo-controlled study of inhaled Leukine® in non-hospitalized patients at risk for severe COVID-19 LEXINGTON, Mass., Dec. 20, 2023 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced today that Open Forum Infectious Diseases recently…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.